30 impacts for 30 years

2023-10-12T09:43:02+01:004 October 2023|

We highlight some of our impacts - from sequencing the human genome, to enabling the diagnosis of rare disease patients around the world.

One childhood cancer, one thousand children: landmark genomic study delivers first discoveries

2023-09-26T11:40:57+01:0025 September 2023|

Tumours from 1000 children with kidney cancer have been sequenced, thanks to the Little Princess Trust and researchers at the Wellcome Sanger Institute. The Little Princess Trust ‘Knowledge Bank’ is the largest comprehensive genomics resource for any childhood solid tumour, and is already being used for research to understand childhood cancers.

Mosaic’s becoming

2023-09-11T16:06:43+01:0012 September 2023|

The Sanger Institute is committed to innovative science at scale, but we need partners and investors to transfer this science into the clinic. Mariya Chhatriwala, Business Development Manager, gives us her insights on how the Sanger Institute’s fifth spin-out company came to be.

What is a gene?

2023-08-10T12:08:28+01:0010 August 2023|

A gene is a string of DNA letters that encode a protein - the building blocks of our cells and bodies. One gene encodes one protein. Simple, right? But scratch the surface into the molecular details and it soon gets complicated. Ongoing research, including work by scientists at the Wellcome Sanger Institute, is unpacking some of this complexity across diverse organisms - and viruses - and helping to reshape what we mean by a “gene”.

Building an atlas of gene variants to understand health and disease

2023-08-07T15:12:11+01:007 August 2023|

Mutational scanning technologies are revolutionising the way we understand human genetic variation. A symposium in July brought together researchers from over 50 countries to explore the possibilities of this incipient genomic method, and how it can benefit clinicians and patients.